1. Home
  2. Analysis
  3. Eylea
  4. Psoriasis

Eylea and Psoriasis - a phase IV clinical study of FDA data

Summary:

Psoriasis is reported as a side effect among people who take Eylea (aflibercept), especially for people who are male, 60+ old, also take Avastin, and have Asthma.

The phase IV clinical study analyzes which people have Psoriasis when taking Eylea. It is created by eHealthMe based on reports of 27,819 people who have side effects when taking Eylea from the FDA, and is updated regularly.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,479 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

On Jul, 12, 2026

27,819 people reported to have side effects when taking Eylea.
Among them, 23 people (0.08%) have Psoriasis.

Could Eylea cause Psoriasis?

Among these 23 people:

What is the gender of people who have Psoriasis when taking Eylea? *

  • female: 26.32 %
  • male: 73.68 %

What is the age of people who have Psoriasis when taking Eylea? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Eylea? *

  1. Avastin: 16 people, 69.57%
  2. Lucentis: 14 people, 60.87%
  3. Albuterol: 7 people, 30.43%
  4. Simvastatin: 7 people, 30.43%
  5. Omeprazole: 7 people, 30.43%
  6. Carbamazepine: 7 people, 30.43%
  7. Aspirin: 7 people, 30.43%
  8. Amitriptyline Hydrochloride: 4 people, 17.39%
  9. Synthroid: 3 people, 13.04%
  10. Acetylsalicylic Acid: 2 people, 8.70%

What are other side effects people have besides Psoriasis? *

  1. Blindness: 15 people, 65.22%
  2. Weakness: 14 people, 60.87%
  3. Pulmonary Thrombosis (scarring in the lungs): 14 people, 60.87%
  4. Agitation (state of anxiety or nervous excitement): 14 people, 60.87%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 14 people, 60.87%
  6. Blindness Unilateral: 14 people, 60.87%
  7. Confusional State: 14 people, 60.87%
  8. Dyspnea (difficult or laboured breathing): 14 people, 60.87%
  9. Fall: 14 people, 60.87%
  10. High Blood Cholesterol: 14 people, 60.87%

What are the existing conditions these people have? *

  1. Pain: 14 people, 60.87%
  2. Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 14 people, 60.87%
  3. Asthma: 14 people, 60.87%
  4. Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 4.35%
  5. Retinal Oedema (swelling of retina): 1 person, 4.35%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Eylea and have Psoriasis?

- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eylea:

Psoriasis treatments and more:

How severe was Psoriasis and when was it recovered:

Expand to all the drugs that have ingredients of aflibercept:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eylea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis:

Browse all the conditions that are associated with Psoriasis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on aflibercept (the active ingredients of Eylea) and Eylea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.